Remote Teamwork Management of NORSE During the COVID-19 Lockdown
Citation Manager Formats
Make Comment
See Comments

Abstract
New-onset refractory status epilepticus (NORSE) is rare condition, and sharing knowledge is vital in its management, based on strict collaboration between multiple specialists, continuous EEG (c-EEG) monitoring, and prompt therapy modification. The coronavirus disease 2019 (COVID-19) pandemic challenged many of these established practices because of “social distancing” measures, making it necessary to work around physical restrictions. We report a case of a 10-year-old with NORSE admitted in a pediatric intensive-care unit and monitored with c-EEG and amplitude-integrated EEG. The monitoring interface was livestreamed using videoconference web-based platforms allowing remote viewing. Multiple daily web meetings took place between team members, where real-time therapy response was evaluated and confronted with medium-term trends in the epileptic activity, dictating further treatment and diagnostic steps. In addition to the known use of telemedicine in chronic conditions, we report how its use can be exploited to treat urgent conditions such as NORSE. By taking advantage of new tools and virtual environments, we were able to share treatment and diagnostic decisions and guarantee real-time therapy adjustments and a coherent course in treatment despite restrictions necessary for the COVID-19 pandemic. The constant specialist monitoring and the coherent and on-time communication of the patient's condition relieved the family stress, usually complained in these situations.
Footnotes
Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.
↵* These authors contributed equally to the manuscript.
- Received August 17, 2020.
- Accepted October 30, 2020.
- © 2020 American Academy of Neurology
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Global Impact of COVID-19 on Stroke Care and IV ThrombolysisRaul G. Nogueira, Muhammad M. Qureshi, Mohamad Abdalkader et al.Neurology, March 25, 2021 -
Commentary
Modification to Neurology Residency TrainingThe Toronto Neurology COVID-19 Pandemic ExperienceRyan T. Muir, Priti Gros, Robert Ure et al.Neurology: Clinical Practice, June 22, 2020 -
Articles
Nonconvulsive seizures are common in critically ill childrenN.S. Abend, A.M. Gutierrez-Colina, A.A. Topjian et al.Neurology, February 09, 2011 -
Article
Cost-effectiveness analysis of multimodal prognostication in cardiac arrest with EEG monitoringEdilberto Amorim, Shirley S. Mo, Sebastian Palacios et al.Neurology, July 13, 2020